Glycogen synthase kinase 3 (GSK-3) is a constitutively active, proline-directed serine (Ser)/threonine (Thr) protein kinase encoded by two isoforms and GSK-3b (approx. 47 kDa)], which possess similar biochemical characteristics and substrate specificities.
In the present study, we used two basic brain proteins [bovine myelin basic protein (bMBP, pIϭ11.3) and human tau protein (hTP, pIϭ8.2)] and two acidic proteins [human vimentin (hVM, pIϭ5.1) and rat collapsing response mediator protein-2 (rCRMP-2, pIϭ6.0)] as effective substrates for GSK-3b in vitro, because (i) these proteins, containing multiple potent phosphorylation sites for GSK-3b, function as effective phosphate acceptors for the kinase in vitro; (ii) GSK3b is identified as a key protein kinase responsible for their functional regulation in brain [7] [8] [9] [10] ; and (iii) phosphatidylinositol (PI) and two sulfated lipids [sulfatide and heparin (SH)] function as effective stimulators for autophosphorylation of GSK-3b and the GSK-3b-mediated high phosphorylation of SH-binding proteins, such as MBP and TP, in the highly accumulated levels of these acidic and sulfated modulators in the brain. 11) A number of epidemiological studies have shown that the consumption of green tea may account for the anti-oxdant, anti-inflammatory, anti-carcinogenic, and neuropotective effects.
12) The chemical structures of four major catechins [(Ϫ)-epigallocatechin gallate (EGCG), (Ϫ)-epigallocatechin, (Ϫ)-epicatechin gallate and (Ϫ)-epicatechin] in green tea have been determined and EGCG is a major polyphenol in green tea and accounts for 50-80% of the total catechins in the tea. 12, 13) Several EGCG-binding proteins, such as plasma proteins (fibronectin, fibrinogen and histidine-rich glycoprotein), 14) fatty acid synthase (Fas), 15) 67 kDa laminin receptor (67-LR), 16) platelet derived growth factor (PDGF), 17) and vimentin (type III intermediate filament protein) 18) have been identified. The N-terminal head (50-63: SLYSSSPG-GAYVTR) of VM is identified as a target for EGCG, which inhibits dose-dependently the A-kinase-mediated phosphorylation of the head fragment, containing two phosphorylation sites at Ser-50 for A-kinase and Ser-55 for Cdc2-kinase, in vitro. 18) Furthermore, early studies concerning the biological effects of EGCG in vivo revealed that (i) green tea polyphenols exhibit potentially anti-amyloidgenic effect and induce to protect neuron-like cells against amyloid b-mediated toxicity 19) ; (ii) EGCG can induce apoptosis preferentially in cancer cells 20) ; and (iii) 67-LR is a cell surface EGCG-receptor, which mediates anti-cancer of the polyphenol in vivo. 21, 22) However, the mechanisms involved in these EGCG-induced biological effects and the physiological regulation of above EGCG-binding proteins by protein kinases, such as GSK-3b, A-kinase and casein kinase 1 (CK1), involved in cell proliferation and apoptosis are still unclear at present.
Since there are no reports concerning the effects of EGCG and its related two compounds (luteolin and quercetin) on autophosphorylation of GSK-3b and the GSK-3b-mediated phosphorylation of functional brain proteins, such as MBP, TP, VM and CRMP-2, the present study has been carried out to (i) determine the effects of EGCG in comparison with lu- teolin and quercetin on the phosphorylation of two basic proteins (bMBP and hrTP) and two acidic proteins (rCRMP-2 and hrVM) by GSK-3b and on autophosphorylation of the kinase; (ii) characterize the EGCG-induced phosphorylation sites for GSK-3b on these two basic proteins; and (iii) determine the kinetics for autophosphorylation of GSK-3b and the GSK-3b-mediated phosphorylation of these two basic proteins in the presence or absence of EGCG in vitro. 
MATERIALS AND METHODS

Chemicals
.).
Purification of CRMP-2 as an Effective Substrate for GSK-3b from Rat Brain Collapsing response mediator protein-2 (CRMP-2) was highly purified from the extract of rat brain by means of successive diethylaminoethyl (DEAE)-cellulose column chromatography, gel filtration of a SDX 200 pg column, heparin-affinity column chromatography. Finally, CRMP-2 (70 kDa polypeptide, p70) in the heparinaffinity fraction was purified by Mono Q column chromatography as a single polypeptide. In these purification steps, p70 in the eluted fractions was detected as a phosphorylated polypeptide by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) followed by autoradiography after the incubation for 20 min at 30°C in reaction mixtures (50 ml) comprising GSK-3b (approx. 50 ng), 40 mM Tris-HCl (pH 7.6), 2 mM DTT, 3 mM Mn 2ϩ and 5 mM [g-32 P]ATP (500 cpm/pmol). Purified p70 was identified as CRMP-2 by matrix assisted laser desorption/ionization-time of flight (MALDI-TOF)-MS analysis.
Assay for GSK-3b Activity in Vitro Four protein substrates (bMBP, hrTP, rCRMP and hrVM: approx. 2 mg each) were separately incubated for 30 min at 30°C in reaction mixtures (50 ml) comprising GSK-3b (approx. 50 ng), 40 mM Tris-HCl (pH 7.6), 2 mM DTT, 3 mM Mn 2ϩ and 5 mM [g-32 P]ATP (500 cpm/pmol) in the presence or absence of EGCG.
32 P-Labeled substrate proteins in the reaction mixtures were separately detected by SDS-PAGE followed by autoradiography. After phosphorylation of these four substrates, protein phosphorylation was terminated by the addition of 0.5 ml 20% trichloroacetic acid (TCA) and 0.25 ml 0.1 M sodium pyrophosphate containing BSA (1 mg/ml) and 10 mM ethylenediaminetetraacetic acid (EDTA). The TCAinsoluble precipitates were trapped on a glass membrane filter (Advantec GF/75), and then washed successively with 2% TCA and 100% ethanol. After drying, the 32 P-radioactivity on the membrane filter was measured with a liquid scintillation spectrophotometer, as described in our previous reports. 11, 23) Phosphopeptide Mapping Briefly, either bMBP or hrTP (approx. 2 mg) in reaction mixtures (50 ml) comprising 40 mM Tris-HCl (pH 7.6), 2 mM DTT, 3 mM Mn 2ϩ and 5 mM [g-32 P]ATP (500 cpm/pmol) in the absence or presence of these two substrate proteins were phosphorylated for 240 min at 30°C by GSK-3b (approx. 50 ng). After SDS-PAGE, trypsin-digested 32 P-labeled MBP or TP was analyzed by TLC electrophoresis under the conditions of 40 mA for 60 min (first dimension) and chromatography (second dimension). Separated 32 P-labeled polypeptides cleaved from bMBP or hrTP were detected by autoradiography, as described in our previous reports. 11, 23) Measurement of the Binding Affinities of EGCG with Four Substrate Proteins by a Quarts Crystal Microbalance (QCM) The binding affinities of four substrate proteins (bMBP, hrTP, rCRMP-2 and hrVM) with EGCG and its related two compounds (luteolin and quercetin) were separately determined by using a QCM (Initium, Tokyo, Japan) using bovine serum albumin (BSA) as an negative control, as described in our previous reports. 11, 23) 
RESULTS
The Effects of EGCG, Luteolin and Quercetin on the GSK-3b-Mediated Phosphorylation of Four Proteins in Vitro
The effects of EGCG, luteolin and quercetin ( Fig. 1 ) on the GSK-3b-mediated phosphorylation of two basic brain proteins (hrTP and bMBP) and two acidic proteins (rCRMP-2 and hrVM) were comparatively determined in vitro. It was found that (i) these four proteins functioned as phosphate acceptors for GSK-3b in the absence of EGCG; (ii) EGCG stimulated the GSK-3b-mediated phosphorylation of two basic proteins (hrTP and bMBP) and hrVM in a dose-dependent manner; and (iii) the maximum phosphorylation of these three proteins by GSK-3b was observed with 1-3 mM EGCG in vitro ( Fig. 2A) . However, the GSK-3b-mediated phosphorylation of rCRMP-2 was inhibited dose-dependently by EGCG and completely inhibited at 1 mM (Fig. 2B ), which was a relative high dose (approx. 0.3 mM) of quercetin. In contrast, EGCG at 1 mM stimulated approx. 4-fold phosphorylation of hrVM by GSK-3b, whereas this phosphorylation was inhibited by luteolin as well as quercetin in a dosedependent manner in vitro (Fig. 3 ). All these results show that (i) EGCG, not quercetin and luteolin, acts as an effective stimulator for the GSK-3b-mediated phosphorylaton of hrTP and as a significant stimulator for the phosphorylaton of bMBP as well as hrVM by the kinase; and (ii) these three polyphenols inhibit dose-dependently the phosphorylation of rCRMP-2 by GSK-3b in vitro.
The Binding Affinities of EGCG with Four Protein Substrates for GSK-3b in Vitro The above results (Figs.  2, 3) suggest that the direct binding of EGCG to three substrate proteins (hrTP, bMBP and hrVM) for GSK-3b may induce to highly stimulate their phosphorylation by the kinase in vitro. To confirm this, the binding affinities of EGCG with four substrate proteins (hrTP, bMBP, rCRMP-2 and hrVM) were comparatively measured using a QCM. As shown in Fig. 4A , EGCG had a high binding affinity with bMBP rather than hrTP, and it had a low affinity with rCRMP-2 rather than hrVM in vitro. Under the same experimental conditions, hrVM had a binding affinity with EGCG rather than quercetin and luteolin (Fig. 4B) . These results show that (i) two basic proteins (hrTP and bMBP) and hrVM are characterized as EGCG-binding proteins; and (ii) EGCG has a low binding affinity with an acidic protein (rCRMP-2) in vitro.
Characterization of the EGCG-Induced High Phosphorylation of hrTP and bMBP by GSK-3b in Vitro To characterize the EGCG-induced high stimulation of the GSK-3b-mediated phosphorylation of two basic proteins (hrTP and bMBP), phosphoaminoacid analysis and phosphopeptide-mapping were performed after the incubation (120 min at 30°C) of GSK-3b with either hrTP and 1 mM EGCG or bMBP and 3 mM EGCG. In the presence of 1 mM EGCG, Ser-residues rather than Thr-residues in the potent phosphorylation sites for GSK-3b on hrTP were preferred as phosphate acceptors for the kinase (Fig. 5A ). Either 32 P-labeled hrTP or bMBP in the reaction mixtures was subjected to SDS-PAGE, after the exhaustive digestion of 32 P-labeled hrTP-band or bMBP-band in-gel with trypsin. Autoradiography (Fig. 5B ) detected at least four normal phosphorylated fragments (spots: 1-4) in hrTP fully phosphorylated by GSK-3b in the absence of EGCG. In contrast, in the presence of 1 mM EGCG, at least four normal spots and four minor inducible spots (a-d) were detected in 32 P-labelled hrTP fully phosphorylated by GSK-3b (Fig. 5B) .
In the case of bMBP after the incubation (120 min at 30°C) with GSK-3b and 5 mM [g-32 P]ATP (500 cpm/pmol) in the presence of 3 mM EGCG, phosphorylation of Ser-residues on bMBP was extremely stimulated when incubated with 3 mM EGCG, whereas phosphorylation of Thr-residues was undetectable (Fig. 6A) . Autoradiography (Fig. 6B ) detected three common phosphorylated fragments (spots: 1-3) generated from the trypsin-digested bMBP, which was fully phosphorylated by GSK-3b in the absence of EGCG. In the presence of 3 mM EGCG, three common spots (1-3) and [A] After these three protein substrates (bMBP, hrTP and hrVM, approx. 2 mg each) were separately incubated for 30 min at 30°C with GSK-3b (approx. 50 ng) and the indicated concentrations of EGCG, 32 P-labeled three proteins in the reaction mixtures were separately analyzed by SDS-PAGE and followed by autoradiography. A stimulation rate of 1 represents the phosphorylation of bMBP (᭹), hrTP (᭺) or hrVM (᭝) by GSK-3b in the absence of EGCG in vitro.
[B] Under the same experimental conditions, the inhibitory effect of EGCG on the GSK-3b-mediated phosphorylation of rCRMP-2 was determined in vitro. One-hundred percent represents the phosphorylation of rCRMP-2 by GSK-3b in the absence of EGCG in vitro.
Fig. 3. The Effects of EGCG, Luteolin and Quercetin on the GSK-3b-Mediated Phosphorylation of hrVM in Vitro
To determine the stimulatory and inhibitory effects of these three polyphenols on the GSK-3b-mediated phosphorylation of hrVM, hrVM (approx. 2 mg) was incubated for 30 min at 30°C with GSK-3b (approx. 50 ng) in the presence of the indicated concentrations of these three polyphenols. After that, 32 P-labeled hrVM in the reaction mixtures was detected by SDS-PAGE followed by autoradiography. The stimulation rate 1 represents the phosphorylation of hrVM by GSK-3b in the absence of these three polyphenols in vitro. EGCG (᭺); quercetin (᭹); and luteolin (). three minor inducible spots (a-c) were detected in 32 P-labeled bMBP fully phosphorylated by GSK-3b (Fig. 6B) . In the case of the GSK-3b-mediated phosphorylation of hrVM in vitro, the GSK-3b-mediated phosphorylation of Ser-and Thr-residues on hrVM was extremely increased when incubated with 1 mM EGCG (Fig. 7A) . Under the assay conditions, autoradiography (Fig. 7B ) detected at least 10 common phosphorylated fragments (spots: 1-10) and four minor inducible spots (a-d) in 32 P-labeled hrVM fully phosphorylated by GSK-3b in the presence of 1 mM EGCG. These results suggest that the direct binding of EGCG to three substrate proteins (hrTP, bMBP and hrVM) results in their conformational changes, which presumably disclose novel phosphorylate sites for GSK-3b on these proteins in vitro.
The Stimulatory Effect of EGCG on Autophosphorylation of GSK-3b in Vitro
The stimulatory effect of EGCG on autophosphorylation of GSK-3b was examined by the direct incubation of the kinase with 5 mM [g-32 P]ATP (500 cpm/pmol) and the indicated concentrations of EGCG in vitro. As shown in Fig. 8A , it was found that (i) EGCG at 0.3 mM stimulated approx. 2.7-fold autophosphorylation of GSK-3b; (ii) quercetin at 0.1 mM slightly enhanced autophosphorylation of the kinase; and (iii) this autophosphorylation was inhibited by these three polyphenols at higher doses over 1 mM in vitro. In the presence of 0.3 mM EGCG, Thr-residues on GSK-3b were preferentially phosphorylated, whereas phosphorylation of Ser-residues was undetectable (Fig. 8B) . These results suggest that the binding of EGCG to GSK-3b may lead to significantly enhance autophosphorylation of the kinase at Thr-residues in vitro.
Autophosphorylation Kinetics of GSK-3b and the GSK-3b-Mediated Phosphorylation Kinetics of bMBP in the Presence of EGCG in Vitro
To understand the stimulatory effect of EGCG on autophosphorylation of GSK-3b, autophosphorylaton kinetics of the kinase were determined in vitro. The apparent K m value of ATP for autophosphorylation of GSK-3b shifted to 0.81 from 1.42 when incubated with 0.3 mM EGCG, whereas the V max value of ATP for the kinase shifted to 0.10 from 0.24 mmol/mg/min (Fig. 9A) . In addition, the GSK-3b-mediated phosphorylation kinetics of [A] 32 P-Labeled phosphoamino acids of hrTP fully phosphorylated by GSK-3b in the absence or presence of 1 mM EGCG were detected by autoradiography after two-dimentional TLC electrophoresis.
[B] hrTP (approx. 2 mg) was incubated for 120 min at 30°C with GSK-3b (approx. 50 ng) and 5 mM [g-32 P]ATP (500 cpm/pmol) in the presence or absence of 1 mM EGCG. After digestion of 32 P-labeled hrTP with trypsin in the gel, the resulting polypeptides were analyzed by TLC electrophoresis and detected by autoradiography. None: without EGCG.
Fig. 6. Detection of Phosphoamino Acids and Peptide Mapping of bMBP Fully Phosphorylated by GSK-3b in the Presence of EGCG in Vitro
[A] 32 P-Labeled phosphoamino acids of bMBP fully phosphorylated by GSK-3b in the absence or presence of 3 mM EGCG were detected by two-dimentional TLC electrophoresis and follwed by autoradiography.
[B] After bMBP (approx. 2 mg) was incubated for 120 min at 30°C with GSK-3b (approx. 50 ng) and 5 mM [g-32 P]ATP (500 cpm/pmol) in the absence or presence of 3 mM EGCG, 32 P-labeled bMBP was digested with trypsin in the gel, the resulting polypeptides were analyzed and detected, as described in Fig. 3 . bMBP in the presence or absence of 3 mM EGCG were determined in vitro. The apparent K m value of bMBP for GSK-3b was changed to 0.18 from 0.50, whereas the V max value of bMBP shifted to 1.25 from 0.76 mmol/mg/min (Fig. 9B) . Under the same experimental conditions, similar phosphorylation kinetics were observed when hrTP was used as a phosphate acceptor for the kinase (data not shown). These results suggest that (i) the direct binding of EGCG to GSK-3b significantly stimulates its autophosphorylation through an increased in the binding affinity of ATP for the kinase; and (ii) the binding of EGCG to these two basic proteins (bMBP and hrTP) for GSK-3b induces to highly stimulate their phosphorylation by the kinase in vitro.
DISCUSSION
In this study, we found that EGCG, not quercetin and luteolin, functioned as an effective stimulator for the GSK-3b-mediated phosphorylation of three substrate proteins [bMBP (pIϭ11.3), hrTP (pIϭ8.2) and hrVM (pIϭ5.1)] in vitro, because (i) EGCG highly stimulated the phosphorylation of these three proteins by GSK-3b (Fig. 2A) ; (ii) EGCG had a binding affinity with these three proteins (Fig. 4) ; and (iii) the binding of EGCG to these three proteins resulted in the induction of their high phosphorylation including novel potent sites for GSK-3b in vitro (Figs. 5-7) . Under the optimum assay conditions for autophosphorylation of GSK-3b, Thr-residues on the kinase were preferentially phosphorylated and this phosphorylation was significantly enhanced with 0.3 mM EGCG (Fig. 8B) . In addition, EGCG, not luteolin and quercetin, highly stimulated the phosphorylation of hrVM by GSK-3b (Fig. 3) , whereas these three polyphenols inhibited dose-dependently the GSK-3b-mediated phosphorylation of rCRMP-2 (pIϭ6.0) in vitro (Fig. 2B) . The EGCG-induced different effects on the GSK-3b-mediated phosphorylation between two acidic proteins (rCRMP-2 and hrVM) may be explained by the following possible reasons: (i) EGCG has a binding affinity with hrVM higher than rCRMP-2 (Fig. 4) ; and (ii) the N-terminal fragment (50-63: SLYSSSPGGAYVTR), containing Ser-55 (a potent phosphorylation site for GSK-3b), of VM is an EGCG-binding target, 18) which is dissimilar to the amino acid sequences of the other domains, containing potent Thr-phosphorylation sites for GSK-3b, on rCRMP-2 in vitro.
Phosphorylation kinetics (Figs. 9A, B) revealed that the incubation of EGCG with GSK-3b and two substrates (ATP and bMBP or hrTP) resulted in the significant reduction of the K m value and an increase in the V max value of ATP and these two proteins for the kinase in vitro. These results suggest that (i) the binding of EGCG to GSK-3b and these two protein substrates may induce to highly stimulate their phosphorylation, including novel potent sites for the kinase; and (ii) EGCG may function as an effective stimulator for GSK3b through the enhancement of Thr-phosphorylation on GSK-3b by its direct binding to the kinase in vitro. It has been reported that the intramolecular autophosphorylation of GSK-3b at Tyr-residures is involved in the regulation of the kinase activity, because its dephosphorylation by tyrosine phosphatase 1B diminishes the kinase activity in vitro. 24) Under our assay conditions, EGCG at 0.3 mM significantly enhanced Thr-phosphorylation of GSK-3b, but no detection of Try-phosphorylation on the kinase was observed (Fig.  8B ). In addition, autophosphorylation of GBK-3b was completely inhibited by 10 mM EGCG, which also completely inhibited the GSK-3b-mediated phosphorylation of three EGCG-binding proteins (hrTP, bMBP and hrVM) in vitro ( Fig. 2A) . These observations strongly suggest that the EGCG-induced Thr-phosphorylation of GSK-3b may be involved in the high stimulation of the GSK-3b-mediated phosphorylation of these three EGCG-binding proteins in vitro.
Our two observations that (i) EGCG at low doses (1- P-Labeled GSK-3b in the reaction mixtures was determined by the membrane filter method, 11) as described in the Materials and Methods. Lineweaver-Burk plots of ATP for GSK-3b in the absence (᭺) or presence of 0.3 mM EGCG (᭹).
[B] Phosphorylation kinetics of bMBP by GSK-3b in the presence or absence of EGCG in vitro. GSK-3b (approx. 50 ng) was incubated for 30 min at 30°C with 5 mM [g-32 P]ATP and the indicated concentrations of bMBP in the absence or presence of 3 mM EGCG in vitro.
32
P-Labeled bMBP in the reaction mixtures was determined by the membrane filter method. Lineweaver-Burk plots of bMBP for GSK-3b in the absence (᭺) or presence of 3 mM EGCG (᭹).
3 mM) highly stimulates the GSK-3b-mediated phosphorylation of hrTP by GSK-3b (Fig. 2A) ; and (ii) this compound has a binding affinity with hrTP in vitro (Fig. 4) , suggest that EGCG may induce the high phosphorylation of TP by the kinase in normal brain. Although it has been reported that GSK-3b is a protein kinase responsible for hyperphosphorylation of TP in an early stage of Alzheimer's disease (AD), 25) one of human neurodegenerative disorder diseases, the EGCG-induced high phosphorylation of TP by GSK-3b is different from the GSK-3b-mediated hyperphosphorylation of TP primed by other Ser/Thr-protein kinases, such as CK1 and A-kinase and C-kinase, which are sensitive to EGCG in vitro. 11, 26) Previously, we reported that both PI and SH can function as effective stimulators for the GSK-3b-mediated phosphorylation of bMBP through their selective binding to the Arg/Lys-rich domains, containing the consensus phosphorylation sites (Ser-residues) for the kinase, on the basic brain protein.
23) The stimulatory effect of EGCG on the GSK-3b-mediated phosphorylation of bMBP and hrTP is similar to those observed with PI and SH in vitro, 23) because (i) the direct binding of EGCG as well as PI and SH to GSK-3b highly enhance autophosphorylation of the kinase; and (ii) the binding of these chemical mediators to two basic proteins (bMBP and hrTP) can induce their conformational changes, which presumably disclose novel potent phosphorylation sites recognized by the kinase on these two proteins in vitro.
In the present study, we confirmed that (i) the stimulatory effect of EGCG on the CK1-mediated phosphorylation of hrTP is similar to these observed with two phospholipids (PI and PS) on its phosphorylation by kinase in vitro 11) ; (ii) the phosphorylation of a-casein by CK2 was sensitive to quercetin more than EGCG in vitro 26) ; (iii) no effects of quercetin and luteolin on the phosphorylation of bMBP and hrTP by A-kinase were observed in vitro, as shown in our previous report 27) ; and (iv) EGCG (ID 50 ϭapprox. 1 mM) inhibited the phosphorylation of rCRMP-2 by A-kinase (data not shown). All these results suggest that EGCG may selectively bind to the domains, containing the EGCG-inducible potent phosphorylation sites for GSK-3b, but not for CK2 and A-kinase, on hrTP and bMBP in vitro.
To clearly understand the biological significance of the EGCG-induced high phosphorylation of at least three EGCG-binding functional proteins (MBP, TP and VM) by GSK-3b, further analytical studies are required to (i) determine the specific binding sites for EGCG on these three proteins; (ii) investigate the physiological significance of the EGCG-stimulated high phosphorylation of these EGCGbinding proteins in mouse brain; and (iii) characterize EGCG as an effective potent stimulator for the GSK-3b-mediated phosphoryation of two EGCG-binding basic proteins and as a potent inhibitor for the phosphorylation of CRMP-2 by the kinase in normal neuron. Furthermore, it is an interesting to determine the effects of EGCG in comparison with quercetin and luteolin on the GSK-3b-mediated phosphorylation of other EGCG-binding proteins, such as human Fas (approx. 37.7 kDa, pIϭ8.29), 15) human platelet-derived growth factor (PDGF, approx. 27.3 kDa, pIϭ9.39) involved in fibroblast contraction of floating collagen gel cell, 17) 67-laminin receptor (LR) involved in the EGCG-induced anti-cancer effect, 21, 22) and b-catenin (approx. 85.5 kDa, pIϭ5.53) involved in Wnt-signal on cell membrane in brain, 28) in vitro and in vivo. Since these EGCG-binding proteins have multiple potent phosphorylation sites for GSK-3b, the further analytical studies can reveal (i) the consensus EGCG-binding sites, containing potent phosphorylation sites for GSK-3b, among these EGCG-binding proteins, including TP, MBP and VM; and (ii) the novel GSK-3b-mediated regulatory mechanism of these EGCG-binding functional proteins at the suitable levels of EGCG as well as two sulfated lipids (sulfatide and heparin) in the brain.
